$30.25
00.00%
Last update: Jul 19, 4:00 PM
15 minutes delayed
Comments
Loading...
Supernus Pharmaceuticals
SUPNNASDAQ
Supernus Pharmaceuticals (NASDAQ:SUPN) Stock, Earnings Estimates, EPS, And Revenue
Supernus Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 6
EPS Estimate
$0.390
Quarterly Revenue Estimate
$148.8M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$597.4M
Analyze the earnings history of Supernus Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPN | Supernus Pharmaceuticals | -$0.02 | $0.39 | — | — | $135.56M | $148.85M | — | — | 08/06/2024 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.29 | $0.38 | $0.00 | -100.00% | $153.76M | $145.83M | $143.64M | -1.50% | 05/08/2024 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.43 | $0.55 | $0.39 | -29.09% | $167.33M | $155.03M | $164.31M | 5.99% | 02/27/2024 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.03 | $0.13 | -$0.29 | -323.08% | $177.35M | $146.14M | $153.88M | 5.30% | 11/08/2023 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.14 | -$0.23 | -$0.02 | 91.30% | $170.05M | $144.38M | $135.56M | -6.11% | 08/08/2023 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.43 | $0.17 | $0.29 | 70.59% | $152.51M | $139.02M | $153.76M | 10.61% | 05/09/2023 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.04 | $0.68 | $0.43 | -36.76% | $159.05M | $180.37M | $167.33M | -7.23% | 02/28/2023 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.40 | $0.36 | $0.03 | -91.67% | $148.46M | $172.48M | $177.35M | 2.83% | 11/08/2022 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.43 | $0.29 | $0.14 | -51.72% | $141.33M | $164.23M | $170.05M | 3.54% | 08/04/2022 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.11 | — | $0.43 | — | $130.93M | — | $152.51M | — | 05/09/2022 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.57 | $0.24 | $0.04 | -83.33% | $143.56M | $149.42M | $159.05M | 6.44% | 04/13/2022 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.74 | $0.23 | $0.40 | 73.91% | $155.13M | $142.12M | $148.46M | 4.46% | 11/03/2021 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.65 | $0.20 | $0.43 | 115.00% | $126.73M | $134.87M | $141.33M | 4.79% | 08/04/2021 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.40 | $0.24 | $0.11 | -54.17% | $94.98M | $129.20M | $130.93M | 1.34% | 05/05/2021 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.62 | $0.52 | $0.57 | 9.62% | $100.45M | $146.19M | $143.56M | -1.80% | 02/25/2021 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.54 | $0.30 | $0.74 | 146.67% | $102.14M | $130.66M | $155.13M | 18.73% | 11/03/2020 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.61 | $0.45 | $0.65 | 44.44% | $104.69M | $127.86M | $126.73M | -0.88% | 08/18/2020 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.34 | $0.28 | $0.40 | 42.86% | $85.47M | $83.48M | $94.98M | 13.77% | 05/05/2020 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.48 | $0.60 | $0.62 | 3.33% | $115.93M | $111.53M | $100.45M | -9.94% | 02/25/2020 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.52 | $0.60 | $0.54 | -10.00% | $103.00M | $109.54M | $102.14M | -6.76% | 11/05/2019 | Get Alert |
| SUPN | Supernus Pharmaceuticals | $0.57 | $0.57 | $0.61 | 7.02% | $99.54M | $108.67M | $104.69M | -3.66% | 08/06/2019 | Get Alert |
Supernus Pharmaceuticals (SUPN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-08 | $0 | $0.38 | -100.0 % |
| Dec 2023 | 2024-02-27 | $0.39 | $0.55 | -29.1 % |
| Sep 2023 | 2023-11-08 | $-0.29 | $0.13 | -323.1 % |
| Jun 2023 | 2023-08-08 | $-0.02 | $-0.23 | 91.3 % |
Supernus Pharmaceuticals (SUPN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-08 | $143.64M | $145.83M | -1.50 % |
| Dec 2023 | 2024-02-27 | $164.31M | $155.03M | 5.99 % |
| Sep 2023 | 2023-11-08 | $153.88M | $146.14M | 5.30 % |
| Jun 2023 | 2023-08-08 | $135.56M | $144.38M | -6.11 % |
FAQ
When is Supernus Pharmaceuticals (NASDAQ:SUPN) reporting earnings?
Supernus Pharmaceuticals (SUPN) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
What were the latest earnings per share (EPS) for Supernus Pharmaceuticals (NASDAQ:SUPN)?
The Actual EPS was $0.00, which missed the estimate of $0.38.
What were Supernus Pharmaceuticals’s (NASDAQ:SUPN) revenues?
The Actual Revenue was $143.6M, which missed the estimate of $145.8M.
Browse earnings estimates, EPS, and revenue on all stocks.